Robert D. Williams

Bimatoprost 0.03% versus travoprost 0.004% in Black Americans with glaucoma or ocular hypertension

R. Noecker, J. Peace, M. Earl, 2003, Advances in therapy.

Ocular hypotensive effect of the Rho kinase inhibitor AR-12286 in patients with glaucoma and ocular hypertension.

G. Novack, Robert D. Williams, C. Kopczynski, 2011, American journal of ophthalmology.

A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma

R. Noecker, S. Roh, M. Dirks, 2006, Advances in therapy.

A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost.

J. A. Stewart, W. C. Stewart, L. A. Nelson, 2008, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.

R. Schiffman, Robert D. Williams, T. Walters, 2005, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Efficacy of bimatoprost in glaucoma and ocular hypertension unresponsive to latanoprost

Robert D. Williams, 2002, Advances in therapy.

A patient preference comparison of Azarga™ (brinzolamide/timolol fixed combination) vs Cosopt® (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension

S. Rauchman, T. Mundorf, Robert D. Williams, 2008, Clinical ophthalmology.

Has Sliding-Clip Renorrhaphy Eliminated the Need for Collecting System Repair During Robot-Assisted Partial Nephrectomy?

R. Frank, D. Thiel, Robert D. Williams, 2017, Journal of endourology.

A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension.

S. Whitcup, C. Felix, A. Batoosingh, 2003, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group.

E. Snyder, Robert D. Williams, I. Adamsons, 1998, Ophthalmology.

Ocular hypotensive effect of the Rho kinase inhibitor AR-12286 in patients with glaucoma and ocular hypertension.

G. Novack, Robert D. Williams, C. Kopczynski, 2011, American journal of ophthalmology.